Latham & Watkins LLP

Favored for its ability to utilize its premier technology and life sciences offerings, Latham & Watkins LLP’s emerging companies and venture capital practice acts for an array of start-ups and growth companies on formations through to funding and exit transactions. The team also represents venture capital funds and other financial institutions on investment and exit strategies. In Silicon Valley, emerging companies chair Benjamin Potter is the key contact for a raft of start-up technology, fintech, healthcare, and life sciences clients; he recently advised Eigen Labs on its $100m Series B financing. Rounding out the lead partners are global department vice chairs Brian Patterson, who sits in San Francisco, and Haim Zaltzman, who splits his time between New York, San Francisco and Silicon Valley. In Century City, Alex Voxman is equipped to advise emerging companies and venture capital funds on the full suite of corporate, M&A, and financing matters, while in Boston Stephen Ranere specializes in venture capital and corporate transactions in the technology and life sciences sectors. Also in Boston, John Chory handles both company formations and subsequent IPOs. The group was boosted in 2024 by the hire of three new partners in San Francisco: duo Seth Gottlieb and Alex Kassai joined from Cooley LLP, while Zachary Fallon joined from technology-focused firm, Ketsal.